[
    [
        {
            "time": "",
            "original_text": "【国元医药】四联苗全年销售可期，后续产品线丰富——康泰生物2019H1点评",
            "features": {
                "keywords": [
                    "四联苗",
                    "全年销售",
                    "产品线",
                    "康泰生物"
                ],
                "sentiment_score": 0.75,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "false",
                "ts_effect_direction": ""
            },
            "scores": {
                "News_content": "【国元医药】四联苗全年销售可期，后续产品线丰富——康泰生物2019H1点评",
                "Correlation": 9,
                "Sentiment": 7,
                "Importance": 8,
                "Impact": 7,
                "Duration": 6,
                "Entity_Density": 8,
                "Market_Scope": 4,
                "Time_Proximity": 5,
                "Headline_Structure": 8,
                "Source_Recency": 5
            }
        },
        {
            "time": "",
            "original_text": "【西南医药|2019中报点评】康泰生物（300601）：业绩符合预期，下半年有望恢复高增长",
            "features": {
                "keywords": [
                    "康泰生物",
                    "业绩",
                    "中报",
                    "高增长"
                ],
                "sentiment_score": 0.8,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "【西南医药|2019中报点评】康泰生物（300601）：业绩符合预期，下半年有望恢复高增长",
                "Correlation": 10,
                "Sentiment": 8,
                "Importance": 9,
                "Impact": 8,
                "Duration": 7,
                "Entity_Density": 10,
                "Market_Scope": 3,
                "Time_Proximity": 6,
                "Headline_Structure": 9,
                "Source_Recency": 6
            }
        }
    ]
]